Search

Search Funnelback University

Search powered by Funnelback
Your query has been expanded to news |u:www.enterprize.cam.ac.uk.  Search for news |u:www.enterprise.cam.ac.uk instead.
21 - 40 of 183 search results for news |u:www.enterprise.cam.ac.uk or news |u:www.enterprize.cam.ac.uk
  1. Fully-matching results

  2. Challenges and Opportunities for Commercialisation of Research out of …

    https://www.enterprise.cam.ac.uk/challenges-and-opportunities-for-commercialisation-of-research-out-of-the-social-sciences/
    Thumbnail for Challenges and Opportunities for Commercialisation of Research out of the Social Sciences – Cambridge Enterprise 25 Oct 2022: The push for commercialising research in the social sciences is relatively new compared to STEM subjects. ... Market-based solutions to address societal problems from academic research should not be presented as a new agenda.
  3. Develop a commercial opportunity – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/for-the-university/develop-a-commercial-opportunity/
    19 Jan 2022: become new areas of research for you.
  4. Impact Insight: Kalamna CIC – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/video/impact-insight-kalamna-cic/
    Thumbnail for Impact Insight: Kalamna CIC – Cambridge Enterprise 12 May 2022: Dr Khalil has spent her career researching how young Arabic learners can be engaged through a new approach to Arabic phonics. ... A licensing arrangement managed by Cambridge Enterprise now enables Kalamna CIC to launch the toolkit to an international
  5. NMC coating information sheet (Gre-7694-20)

    https://www.enterprise.cam.ac.uk/wp-content/uploads/2022/03/NMC-coating-information-sheet-Gre-7694-20.pdf
    9 Feb 2022: Professor Dominic Wright leads internationally-respected research into new synthetic routes to a broad range of main group and transition metal compounds.
  6. Centessa Pharmaceuticals – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/case-studies/centessa-pharmaceuticals-three-portfolio-companies-merge-into-a-new-pharmaceutical-giant/
    Thumbnail for Centessa Pharmaceuticals – Cambridge Enterprise 11 Apr 2022: 16 February 2022. Centessa Pharmaceuticals: Three portfolio companies merge into a new pharmaceutical giant. ... The new company was launched with $250 million in Series A financing—one of the biggest in recent years—led by blue-chip investors.
  7. Murid herpesvirus-4 (MuHV 4) Antibodies - Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/reagents/murid-herpes-virus-4-antibodies/
    Thumbnail for Murid herpesvirus-4 (MuHV 4) Antibodies - Cambridge Enterprise 9 May 2022: Mouse monoclonal antibodies raised against Murid herpesvirus-4 (MuHV 4) developed at the University of Cambridge.
  8. The Chris Abell Postdoc Business Plan Competition 2022 – Cambridge…

    https://www.enterprise.cam.ac.uk/events/the-chris-abell-postdoc-business-plan-competition-2022/
    Thumbnail for The Chris Abell Postdoc Business Plan Competition 2022 – Cambridge Enterprise 3 May 2022: The Chris Abell Postdoc Business Plan Competition is a programme designed to help accelerate the creation of businesses from University research.
  9. Cambridge Enterprise licenses unique new device for cancer diagnosis…

    https://www.enterprise.cam.ac.uk/news/cambridge-enterprise-licences-unique-new-device-for-cancer-diagnosis/
    Thumbnail for Cambridge Enterprise licenses unique new device for cancer diagnosis – Cambridge Enterprise 15 Nov 2022: 1 November 2022. Cambridge Enterprise licenses unique new device for cancer diagnosis.
  10. The University of Cambridge ecosystem – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/about/our-role-within-the-cambridge-ecosystem/within-the-university/
    20 Jul 2022: i-Teams. The i-Teams innovation programme brings together multi-disciplinary teams of post-graduates with industry mentors and real Cambridge inventions to assess the commercial viability of new technologies and ... We currently run 2 courses a term,
  11. Impact Insight: iKVA – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/video/impact-insight-ikva/
    Thumbnail for Impact Insight: iKVA – Cambridge Enterprise 12 May 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. Impact Insight: iKVA. Share:. This Impact Insight video tells the story behind the creation of iKVA. iKVA is a University of Cambridge spin-out that uses artificial intelligence (AI) to
  12. Science and Technology Facilities Council (STFC) Knowledge Exchange…

    https://www.enterprise.cam.ac.uk/grant/science-and-technology-facilities-council-stfc-knowledge-exchange-and-commercialisation-kec-fellowships/
    18 Jan 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. Science and Technology Facilities Council (STFC) Knowledge Exchange and Commercialisation (KEC) Fellowships. The KEC Fellowship scheme is designed to facilitate the development of
  13. DIOSynVax: tackling COVID-19 – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/case-studies/diosynvax-tackling-covid-19/
    Thumbnail for DIOSynVax: tackling COVID-19 – Cambridge Enterprise 11 Apr 2022: Historically, the creation of an effective new vaccine has required years of work and hundreds of millions of pounds.
  14. CAM2 software for hearing aid fitting – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/reagents/cam2-software-for-hearing-aid-fitting/
    Thumbnail for CAM2 software for hearing aid fitting – Cambridge Enterprise 9 May 2022: CAM2 has been developed to provide a superior solution for the tailoring of wide-band hearing aid parameters using the audiogram alone, and is an essential new tool in the audiology
  15. New Head at Cambridge Enterprise Seed Funds | University of Cambridge

    https://www.enterprise.cam.ac.uk/news/new-head-at-cambridge-enterprise-seed-funds/
    Thumbnail for New Head at Cambridge Enterprise Seed Funds | University of Cambridge 7 Apr 2022: Search. Search. New Head at Cambridge Enterprise Seed Funds. News. New Head at Cambridge Enterprise Seed Funds.. ... Share. Published. 07 Apr 2022. Search news. Sign up to receive our newsletter.
  16. Research tools licensing – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/for-the-university/develop-a-commercial-opportunity/research-tools/
    19 Dec 2022: We have been licensing research tools for over a decade and can therefore fully support you through the process.
  17. Impact Insight: Xampla – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/video/impact-insight-xampla/
    Thumbnail for Impact Insight: Xampla – Cambridge Enterprise 12 May 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. Impact Insight: Xampla. Share:. Impact Insight video case study: Xampla. The first in our series of Impact Insight videos focuses on Xampla. It tells the exciting story of the research
  18. Research Report Commercialisation and Policy Research Authors: Dr…

    https://www.enterprise.cam.ac.uk/wp-content/uploads/2022/12/Roundtable-report_Commercialisation_PolicyResearch.pdf
    15 Dec 2022: Market-based solutions comprise many arrangements, such as licensing innovative tools, creating new companies (including social ventures), carrying out consultancies, and bringing. ... The above reduces the possibilities that usually originate from
  19. Impact Insight video case study: Xampla – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/case-studies/impact-insight-video-case-study-xampla/
    Thumbnail for Impact Insight video case study: Xampla – Cambridge Enterprise 15 Mar 2022: The first in our new series of Impact Insight videos focuses on Xampla. ... Whether you’re a University researcher or academic with a novel idea or technology, an investor keen to support innovations emerging from the University, or an external
  20. The Carbon Challenge: Daily Decarbonisation – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/news/carbon-challenge-2022/
    Thumbnail for The Carbon Challenge: Daily Decarbonisation – Cambridge Enterprise 28 Jan 2022: For news on upcoming Carbon Challenge events and how to register, visit our Events pages.
  21. KARPAS 25 Human Myeloma cell line

    https://www.enterprise.cam.ac.uk/reagents/karpas-25-human-myeloma-cell-line/
    Thumbnail for KARPAS 25 Human Myeloma cell line 9 May 2022: KARPAS 25 Human Myeloma cell line useful in oncology research, developed at the University of Cambridge.

Refine your results

Format

Search history

Recently clicked results

Recently clicked results

Your click history is empty.

Recent searches

Your search history is empty.